Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

December 31, 2007

Conditions
AlbuminuriaDiabetic Nephropathy
Interventions
DRUG

XL784

XL784 softgel capsules (100 mg per capsule) orally administered at a dose of 200 mg/day (or placebo softgel capsules)

Trial Locations (45)

10461

Montefiore Medical Center, The Bronx

20003

MedStar Clinical Research Center, Washington D.C.

21204

MODEL Clinical Research, Baltimore

22908

University of Virginia Health System, Nephrology Division, Charlottesville

27710

Duke South, Durham

29651

Mountain View Clinical Research, Inc., Greer

33021

The Center for Diabetes and Endocrine Care, Hollywood

33028

Pines Clinical Research, Inc., Pembroke Pines

33134

Clinical Research of South Florida, Coral Gables

34741

FPA Clinical Research, Kissimmee

35215

Parkway Medical Center, Birmingham

35565

Winston Technology, Inc., Haleyville

37205

Nephrology Associates, PC, Nashville

37825

Heartland Medical, PC, New Tazewell

39501

South Mississippi Nephrology, Gulfport

43210

The Ohio State University Medical Center, Division of Nephrology, Columbus

44109

Division of Nephrology/Department of Medicine, Case Western Rserve University, MetroHealth Medical Center Campus, Cleveland

48201

Center for Urban and African American Health, Detroit

53295

Zablocki Veterans Affairs Medical Center, Nephrology Section, Milwaukee

63117

Clayton Medical Research, St Louis

64128

Kansas City VA Medical Center, Kansas City

68131

Creighton Dibetes Center, Omaha

68198

University of Nebraska Medical Center - Nephrology, Omaha

70809

Renal Associate of Baton Rouge, Baton Rouge

73103

COR Clinical Research, LLC, Oklahoma City

78229

dgd Research, San Antonio

University of Texas Health Science Center at San Antonio, San Antonio

79705

Diabetes Center of the Southwest, Midland

80214

Western Nephrology and Metabolic Bone Disease, PC, Lakewood

80260

Western Nephrology and Metabolic Bone Disease, PC, Thornton

83404

Rocky Mountain Diabetes and Osteoporosis Center, PA, Idaho Falls

85209

Redpoint Research, Phoenix

90057

National Research Institute, Los Angeles

90073

West Los Angeles VA Medical Center, Los Angeles

90095

UCLA Medical Center, Center for the Health Sciences, Los Angeles

91105

Arroyo Research Inc., Pasadena

91911

International Clinical Research Network, Inc., Chula Vista

92037

Scripps Clinic, Torrey Pines, Division of Nephrology, La Jolla

97504

Clinical Research Institute of Southern Oregon, PC, Medford

06850

Soundview Research Associates, Norwalk

06708

Chase Medical Research, LLC, Waterbury

04102

Intermed, Portland

02215

Renal Unit, Joslin Diabetes Center, Boston

01608

Fallon Clinic Inc. at Worcester Medical Center, Department of Nephrology, Worchester

07006

LAND Clinical Studies, LLC, West Caldwell

All Listed Sponsors
lead

Symphony Evolution, Inc.

INDUSTRY

NCT00312780 - Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy | Biotech Hunter | Biotech Hunter